2021 ESC/EACTS Guidelines for the management of valvular heart disease: developed by the Task Force for the management of valvular heart disease of the …

A Vahanian, F Beyersdorf, F Praz… - European heart …, 2022 - academic.oup.com
Health professionals are encouraged to take the ESC/EACTS Guidelines fully into account
when exercising their clinical judgment, as well as in the determination and the …

Cardiovascular Toxicity of Proteasome Inhibitors: Underlying Mechanisms and Management Strategies: JACC: CardioOncology State-of-the-Art Review

G Georgiopoulos, N Makris, A Laina, F Theodorakakou… - Cardio Oncology, 2023 - jacc.org
Proteasome inhibitors (PIs) are the backbone of combination treatments for patients with
multiple myeloma and AL amyloidosis, while also indicated in Waldenström's …

2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of …

G Mancia, R Kreutz, M Brunström, M Burnier… - Journal of …, 2023 - journals.lww.com
Document Reviewers: Luis Alcocer (Mexico), Christina Antza (Greece), Mustafa Arici
(Turkey), Eduardo Barbosa (Brazil), Adel Berbari (Lebanon), Luıs Bronze (Portugal), John …

[HTML][HTML] Antiplatelet therapy after percutaneous coronary intervention

DJ Angiolillo, M Galli, JP Collet, A Kastrati… - …, 2022 - ncbi.nlm.nih.gov
Antiplatelet therapy is key to reducing local thrombotic complications and systemic
ischaemic events among patients undergoing percutaneous coronary interventions (PCI) …

High-sensitivity cardiac troponin on presentation to rule out myocardial infarction: a stepped-wedge cluster randomized controlled trial

A Anand, KK Lee, AR Chapman, AV Ferry… - Circulation, 2021 - Am Heart Assoc
Background: High-sensitivity cardiac troponin assays enable myocardial infarction to be
ruled out earlier, but the safety and efficacy of this approach is uncertain. We investigated …

Effects on mortality and major bleeding of radial versus femoral artery access for coronary angiography or percutaneous coronary intervention: meta-analysis of …

G Gargiulo, D Giacoppo, SS Jolly, J Cairns, M Le May… - Circulation, 2022 - Am Heart Assoc
Background: In some randomized clinical trials, transradial access (TRA) compared with
transfemoral access (TFA) was associated with lower mortality in patients with coronary …

Impact of admission hyperglycemia on short and long-term prognosis in acute myocardial infarction: MINOCA versus MIOCA

P Paolisso, A Foà, L Bergamaschi, F Angeli… - Cardiovascular …, 2021 - Springer
Background The prognostic role of hyperglycemia in patients with myocardial infarction and
obstructive coronary arteries (MIOCA) is acknowledged, while data on non-obstructive …

Differential diagnosis of suspected chronic obstructive pulmonary disease exacerbations in the acute care setting: best practice

BR Celli, LM Fabbri, SD Aaron, A Agusti… - American Journal of …, 2023 - atsjournals.org
Patients with chronic obstructive pulmonary disease (COPD) may suffer from acute episodes
of worsening dyspnea, often associated with increased cough, sputum, and/or sputum …

[HTML][HTML] Safety and prognostic relevance of acetylcholine testing in patients with stable myocardial ischaemia or myocardial infarction and non-obstructive coronary …

RA Montone, R Rinaldi, MG Del Buono… - …, 2022 - ncbi.nlm.nih.gov
Background Intracoronary provocation testing with acetylcholine (ACh) is crucial for the
diagnosis of functional coronary alterations in patients with suspected myocardial ischaemia …

[HTML][HTML] Impact of clinical presentation on bleeding risk after percutaneous coronary intervention and implications for the ARC-HBR definition: Clinical presentation …

F Gragnano, A Spirito, N Corpataux, L Vaisnora… - …, 2021 - ncbi.nlm.nih.gov
Background The identification of bleeding risk factors in patients undergoing percutaneous
coronary intervention (PCI) is essential to inform subsequent management. Whether clinical …